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INTRODUCTION
Sarcoidosis is a chronic systemic granulomatous disease of unknown etiology characterized by accumulation of activated T-lymphocytes and mononuclear phagocytes forming non-caseating epitheloid granuloma in the affected organs (1, 2) . The recognition of race as an important risk factor clearly suggests a genetic predisposition to develop sarcoidosis. The underlying pathophysiology of the disorder could be explained as an antigen-driven process, which in genetically susceptible people leads to an exaggerated Th1 type immunological response (3) .
One of the possible mechanisms is functional polymorphism of the angiotensin converting enzyme (ACE) gene. The ACE gene, located on chromosome 17q23, contains many polymorphisms. The insertion/deletion (I/D) polymorphism in intron 16 is the most studied polymorphism (4) . The genotype is classified into three types: deletion homozygotes (D/D), insertion homozygotes (I/I) and heterozygotes (I/D). Serum ACE levels corresponding to ACE I/D genotypes in the order I/I < I/D < D/D encouraged investigating the influence of this variation on sarcoidosis susceptibility (5, 6) . Some studies have not found association between ACE I/D polymorphism and the incidence of sarcoidosis (4, (7) (8) (9) . By contrast D/D genotype conferred a threefold increased in risk for sarcoidosis in African-Americans though lack of association between ACE gene polymorphism and sarcoidosis in Caucasians in the same study (10) . Also D allele is a possible risk factor for development of sarcoidosis in Japanese women (11) . Additionally a striking over-representation of the D/D genotype in sarcoidosis patients and in unaffected relatives has established in Germans (12) .
The aim of our study was to examine the distribution of the ACE I/D genotypes in Turkish patients with sarcoidosis and healthy controls to identify a whether it is genetic risk factor for sarcoidosis.
PATIENTS and METHODS

Study Subjects
Between September 2010 and December 2010, 70 sarcoidosis patients were enrolled from the outpatient clinic of Chest Diseases Department, Uludag University Medical Faculty. Diagnosis of sarcoidosis was based on histological evidence. Skin and lymph node involvement was attributed to sarcoidosis only if it was proven histologically. Spleen involvement was based on radiological findings. All patients had received the appropriate treatment for care of the disease. As a control group we studied 69 healthy age and sex matched subjects. All patients and control subjects were Turkish and unrelated to each other. All participated (patients and control subjects) in the study after they had given their full informed and written consent. The study was approved by the Ethics Committee of the Uludag University Medical School.
DNA Extraction and Genotyping
Blood samples were obtained in EDTA tubes both from the patients and controls. DNA was isolated according to the Dr. Zeydanlı (DZ) DNA isolation kit procedure and then stored at -20°C. The ACE gene I/D polymorphism was determined using the polymerase chain reaction (PCR) method. The primers used to determine ACE I/D polymorphism were F: 5'-CTG GAG ACC ACT CCC ATC CTT TCT 3' and R: 5' GAT GTG GCC ATC ACA TTC GTC AGA T-3', and the D/D genotype insertion area specific primer: F: 5'-TGG GAC CAC AGC GCC CGC CCG CCA CTA C-3' and R: 5'-TCG CCA GCC CTC CCA TGC CCA TAA-3'. To prevent incorrect D/D genotyping in samples of ACE D/D genotype, the results were confirmed with a second PCR analysis. PCR conditions were as follows: after the first denaturation for 5 min at 94°C, denaturation continued for 1 min at 94°C, which continued with 35 cycles of annealing for 1 min at 57°C (for verification of D/D genotype, at 63°C), and extension for 1 min at 72°C, which ended with final extension for 10 min at 72°C (13).
After PCR, the samples were separated by 2% agarose gel electrophoresis, stained with ethidium bromide and photographed for the amplification study. As a result of the amplification study, the agarose gel showed an amplification band of 190 bp in samples with the DD genotype, bands of 490 and 190 bp in samples with the ID genotype and a band of 490 bp in samples with the II genotype ( Figure 1 ). In the second PCR analysis conducted for DD confirmation, an amplification band of 335 bp was observed with samples that had the insertion band.
Statistical Analysis
The SPSS 13.0 program was used for the analysis. All data were reported in terms of mean ± standard deviation (SD). A chi-squared test was used to compare genotypes and also genotypes/extrapulmonary involvement. P value less than 0.05 was accepted as statistical significance.
RESULTS
The mean age was 46.64 ± 10.5 years and 44.86 ± 10.83 for the patient group (15 males and 55 females) and the control group (24 males and 45 females) respectively. There was no significant difference in terms of age and gender between the two groups ( Table 1) . Nine patients had skin involvement, one patient had lymph node involvement and one patient had spleen involvement.
Characteristics and genotype distributions of ACE gene I/D polymorphism for both groups are tabulated (Table  1) . No significant difference in allele frequencies for all polymorphisms was observed between sarcoidosis and control groups, although the D allele was more frequent in the sarcoidosis group (p> 0.05) (Table 1, Figure 2 ). The D allele frequencies of ACE gene I/D polymorphism in sarcoidosis in published studies before are summarized ( Table 2) . Out of nine patients with skin involvement, three patients had D/D, four patients had I/D and two patients had I/I allele. One patient with spleen involvement had I/D allele and one patient with lymph node involvement had I/D allele. Similarly there was not significant difference between sarcoidosis patients with extrapulmonary involvement and sarcoidosis patients without extrapulmonary involvement in terms of D/D, I/D and I/I allele frequencies (p> 0.05). Further analysis showed that also ACE genotype was not associated with skin involvement. However due to low numbers of sarcoidosis patients with extrapulmonary involvement, we can not exclude type II error.
DISCUSSION
The discovery that an I/D polymorphism in intron 16 of the ACE gene contributes to the ACE activity in a healthy population was soon followed by studies of the role for this polymorphism in sarcoidosis patients (14) . The D allele is reported to be a predisposing factor to high serum ACE levels both in normal subjects and in patients with sarcoidosis (15).
We have reported that there is no association between ACE gene I/D gene polymorphism and risk of sarcoidosis in Turkish people based on our prospective study. Although frequency of D allele was higher in the sarcoidosis patients group, significant difference was not observed between the D allele frequencies of two groups. te. As a result these studies have showed that frequency of genotypes can be different according to the population (4, (7) (8) (9) (10) (11) (12) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (8) . Although the frequency of the D allele was higher in control subjects and sarcoidosis patients, the difference was not statistically significant. However, Furuya et al. found an over-represantation of the allele D in Japanese sarcoidosis patients as compared with Japanese control (11) . While this phenomenon was significant in female, there was no clear difference in male patients. Maliarik et al. studied African Americans and Caucasians (10). There was not significant diffe- 
